Your browser does not support JavaScript!

Matières premières

351 entreprises et organismes intervenants dans le domaine 'Matières premières', classés par activité.

Rejoignez la communauté
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 2 semaines

Dragonfly Therapeutics in $695M cancer R&D pact with Merck

Il y a 2 semaines
More than a year after insect-inspired biotech Dragonfly Therapeutics penned a blood cancer pact with big biotech Celgene, it's back at the deal table with a potentially meaty biobucks deal with...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 semaines

Agenus sells cut of Incyte, Merck milestone streams

Le 21/09/2018
Agenus has sold a portion of the royalties and milestones it is due to receive from Incyte and Merck. Xoma is paying $15 million for 10% of the $600 million in milestones Agenus is in line to pocket...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 18/09/2018

The Merck Advance Biotech Grant Program: Nurturing the Seeds of Innovative Therapies

Le 17/09/2018
Development of innovative therapies is mostly carried out by small and mid-size biotechs. Often however, the financial burden becomes too heavy just when the new molecule is ready to move to the...
labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 27/08/2018

Merck KGaA, GlucoMe to pilot remote, digital diabetes care in Vietnam

Le 24/08/2018
Merck KGaA has tapped digital diabetes platform provider GlucoMe for a pilot collaboration in several hospitals across Vietnam, the country with the fastest-growing rate of the disease in Southeast...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 07/08/2018

Merck, HitGen expand DNA library screening collaboration

Le 06/08/2018
Merck and HitGen have upsized their licensing agreement into a full-fledged, multiyear drug discovery collaboration, with plans to screen DNA-encoded libraries for new small molecule assets....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 30/07/2018

MilliporeSigma, InnoCore team up on extended-release platform for large biologics

Le 27/07/2018
Merck KGaA’s U.S. life science arm, MilliporeSigma, will collaborate with InnoCore Pharmaceuticals to offer a drug delivery platform for sustained-release formulations for “virtually any class” of...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 25/07/2018

Merck posts 96-week doravirine HIV data as PDUFA date nears

Le 24/07/2018
Merck has posted 96-week data on an HIV prospect it hopes will replace drugs including Bristol-Myers Squibb’s Sustiva in combination regimens. The update linked Merck’s doravirine to a higher rate of...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de L'Usine Nouvelle
Le 27/06/2018

Merck investit 15 millions d’euros supplémentaires à Molsheim

Le 26/06/2018
Le site bas-rhinois de l’Allemand Merck engrange une bonne nouvelle supplémentaire. Après la construction d’un "collaboration center" pour 10... - Quotidien des Usines
www.usinenouvelle.com
ABBOTT
est cité dans une actualité de FierceBiotech
Le 26/06/2018

Senseonics’ recently approved implantable glucose monitor wins real-world accuracy study

Le 25/06/2018
A three-way comparison of continuous glucose monitoring devices found that Senseonics’ recently approved Eversense implantable monitor was significantly more accurate than the Dexcom G5 and the Abbott...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 25/05/2018

Foundation Medicine to develop MSI diagnostic for Merck’s Keytruda

Le 25/05/2018
Merck is pairing up with Foundation Medicine to develop a pan-cancer companion diagnostic for its Keytruda immunotherapy to measure microsatellite instability across all solid tumors, as well as tumor...
www.fiercebiotech.com
Charger plus d'actualités